Jeffrey Bertolini has filed a Form 144 to sell shares of Carlsmed, Inc., a company in the surgical and medical instruments sector. The filing, dated October 30, 2026, indicates that Bertolini plans to sell 243 shares, valued at approximately $3,839. This sale is part of his ongoing relationship with the company, where he serves as an officer.

Carlsmed, Inc. is incorporated in Delaware and operates out of Carlsbad, California. It is classified under the SIC code for Surgical & Medical Instruments & Apparatus. The company is publicly traded on the NASDAQ under the SEC file number 001-42756. The recent filing is part of a series of disclosures made by Bertolini, including multiple transactions in the past few months.

The filing states that Bertolini acquired the shares through a stock option exercise on the same day he plans to sell them. The document notes that he has sold shares in the past three months, including transactions on July 30, August 3, August 4, August 31, September 3, September 30, and October 5 of this year. These sales included various amounts of shares, with gross proceeds totaling over $150,000.

This activity may affect investors and stakeholders in Carlsmed, Inc. as it reflects the ongoing trading behavior of a key officer within the company. The market may interpret these transactions as a signal of Bertolini's confidence in the company's future or as a standard practice of managing personal finances.

The filing does not say what happens next regarding Bertolini's future transactions or any potential company announcements.